Opportunity Information: Apply for CDC RFA GH12 1235
Apply for CDC RFA GH12 1235
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Increasing the Supply of Safe Blood for Transfusions in the United Republic of Tanzania and Zanzibar through Blood Collection, Donor Mobilization, and Technical Assistance under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 30, 2012 and posted on Mar 23, 2012.
- Applicants must submit their applications by May 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $7,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Tanzania suffers from an acute shortage of blood donors, and the current number of donations is estimated to be only about 20 of the World Health Organization s (WHO) estimated minimum requirements for the country. There are only three organizations with the capacity and infrastructure to collect blood for transfusions in Tanzania The National Blood Transfusion Service (NBTS), the Tanzanian People s Defense Force (TPDF), and the Tanzania Red Cross Society (TRCS). The NBTS is a Tanzanian government agency established with CDC funds through the support of Funding Opportunity Announcement 04077 in 2004. Since that time, CDC has supported NBTS and secured them technical assistance to prepare the agency to meet the nation s blood supply needs. CDC currently provides 80 of the budget for this Tanzanian government agency through flat funding with the remaining 20 supplied by the Ministry of Health and Social Welfare. The Tanzanian People s Defense Force is the national military whose narrow blood collection efforts are funded through a sub grant from NBTS. TPDF collections are limited solely to donor recruitment among the small population of their own service members. Therefore the only eligible organization who can supplement and coordinate technical assistance for the blood collection efforts of NBTS using existing infrastructure is the Tanzania Red Cross Society. In March 2010, as part of their HHS/CDC funded cooperative agreement, NBTS established a five year plan including national blood collection targets. Despite considerable efforts on the part of NBTS, they have missed their blood collection milestones to date. Tanzania s national safe blood unit needs are too heavy a burden for NBTS to achieve with its current resources and organizational capacity. NBTS requires supplementary collection efforts and technical assistance to catch up to their five year plan collection goals by 2015. Because NBTS is already two years into their plan, urgent supplementary efforts leveraging existing blood collection infrastructure are necessary. As described above, TRCS is the only non governmental organization possessing this existing blood collection infrastructure.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA GH12-1235) is a CDC discretionary cooperative agreement under PEPFAR focused on increasing the supply of safe blood for transfusions in the United Republic of Tanzania and Zanzibar. The central goal is to raise blood collection levels by supporting blood collection activities, strengthening donor mobilization and recruitment, and providing hands-on technical assistance that helps Tanzania meet national blood supply targets. The grant is positioned as an urgent, gap-filling intervention because the country faces a severe blood shortage and needs faster progress toward its national plan milestones.
The need is described as acute: Tanzania is collecting only about 20 percent of the World Health Organization estimated minimum blood donation requirement for the country. This shortfall has direct implications for patient care, including emergency obstetric care, trauma, pediatric anemia, surgeries, and care for people living with HIV who may require transfusions. The announcement emphasizes that safe blood availability is a national-level burden that the existing government service cannot meet alone at its current capacity and pace, especially because it is already behind on a time-bound five-year plan.
A major feature of the opportunity is that it is intentionally limited to an organization that can immediately leverage existing blood collection infrastructure already operating in Tanzania. Only three entities are described as having the capacity and infrastructure to collect blood for transfusions in Tanzania: the National Blood Transfusion Service (NBTS), the Tanzanian People s Defense Force (TPDF), and the Tanzania Red Cross Society (TRCS). NBTS is the government agency that leads the national program and was originally established with CDC support in 2004. CDC is also described as providing the majority of NBTS funding (about 80 percent), with the remaining 20 percent supported by the Ministry of Health and Social Welfare. TPDF has limited blood collection activity funded via a sub-grant from NBTS, but those collections are narrow in scope because donor recruitment is largely restricted to military service members. As a result, the announcement explains that TRCS is the only non-governmental organization with the necessary existing infrastructure to supplement NBTS blood collection and coordinate technical assistance using systems that are already in place and functioning.
The program context is tied to a five-year plan created by NBTS in March 2010 that established national blood collection targets. Despite significant efforts, NBTS had not met its milestones as of the time of the announcement. Since the plan period was already underway, the opportunity stresses the need for rapid, supplementary efforts to help the country catch up and still achieve the 2015 collection goals. In practical terms, CDC is looking for a partner that can quickly scale up collection and donor mobilization without needing to build a new national system from scratch.
Because the funding instrument is a cooperative agreement, the CDC is expected to have substantial programmatic involvement rather than simply providing funds with minimal oversight. That typically implies close collaboration with CDC on planning, performance monitoring, technical guidance, and alignment with national strategies and PEPFAR priorities. The activities referenced in the title and description include (1) blood collection, meaning increasing the volume of donated blood units collected through existing sites and mobile drives; (2) donor mobilization, meaning targeted outreach, recruitment, and retention strategies to increase the number of regular voluntary donors; and (3) technical assistance, meaning operational support to improve planning, logistics, coordination, and implementation capacity so that supplemental collection efforts integrate effectively with NBTS rather than operating as a separate parallel system. The overall intent is to increase the supply of safe blood for transfusion, which implicitly includes maintaining standards that protect recipients from transfusion-transmitted infections and ensure appropriate handling and processing.
The award profile shows an estimated total funding amount of 7,500,000 with an award ceiling of 1,500,000, and the expected number of awards is one. There is no cost sharing or matching requirement listed. The funding activity category is health, and the CFDA number is 93.067 (Global AIDS), reflecting PEPFAR alignment and the broader HIV-related public health rationale for strengthening transfusion safety and availability. The timeline provided shows the opportunity was posted March 23, 2012, created March 30, 2012, and closed May 7, 2012, with an archive date of June 6, 2012.
Eligibility is effectively constrained by capacity and infrastructure realities described in the announcement. While the eligible applicants field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," the narrative makes clear that TRCS is the only organization positioned to carry out the required supplemental blood collection and coordinate technical assistance alongside NBTS using existing national infrastructure. The announcement frames this as a necessity: Tanzania cannot afford delays caused by building new systems, and supplementing NBTS quickly is required to address missed milestones and the large national need.
For access and administrative questions, the opportunity lists the CDC Procurement and Grant Office as the contact point (pgotim@cdc.gov, 770-488-2700), indicating where applicants would have sought help accessing the full announcement or clarifying application requirements.
FAQs: CDC RFA GH12-1235 (Tanzania and Zanzibar Safe Blood Supply)
What is CDC RFA GH12-1235?
CDC RFA GH12-1235 is a CDC discretionary cooperative agreement under PEPFAR focused on increasing the supply of safe blood for transfusions in the United Republic of Tanzania and Zanzibar. The opportunity is framed as an urgent, gap-filling intervention to help the country accelerate progress toward national blood supply targets.
What is the main goal of this funding opportunity?
The central goal is to raise blood collection levels in Tanzania and Zanzibar by supporting blood collection activities, strengthening donor mobilization and recruitment, and providing hands-on technical assistance to help Tanzania meet national blood supply targets and milestones.
Why is this opportunity considered urgent?
The announcement describes a severe national blood shortage and notes that Tanzania is behind on a time-bound five-year national plan. Because the plan period is already underway, the CDC emphasizes the need for rapid supplementary action rather than building new systems that would take time to establish.
How severe is the blood shortage described in the announcement?
The notice states Tanzania is collecting only about 20 percent of the World Health Organization estimated minimum blood donation requirement for the country, indicating a major gap between need and available supply.
What patient care areas are affected by the blood shortage?
The opportunity links the shortage to direct implications for patient care, including emergency obstetric care, trauma care, pediatric anemia treatment, surgeries, and care for people living with HIV who may require transfusions.
What types of activities does the grant support?
The description highlights three core activity areas: (1) blood collection (increasing donated blood units through existing sites and mobile drives), (2) donor mobilization (outreach, recruitment, and retention strategies to increase regular voluntary donors), and (3) technical assistance (hands-on operational support to improve planning, logistics, coordination, and implementation capacity in alignment with national systems).
What does “blood collection” mean in the context of this opportunity?
Blood collection refers to increasing the volume of donated blood units collected, using existing blood collection sites and mobile blood drives rather than creating a new national collection system.
What does “donor mobilization and recruitment” mean here?
Donor mobilization and recruitment refers to targeted outreach and strategies designed to increase the number of donors and encourage repeat, regular voluntary donation to improve the reliability of the blood supply.
What does “technical assistance” mean for this cooperative agreement?
Technical assistance is described as hands-on operational support to strengthen planning, logistics, coordination, and implementation so that supplemental collection efforts integrate effectively with the national blood program rather than operating as a separate parallel system.
How does this opportunity relate to Tanzania’s national blood program?
The program context is tied to a five-year plan created by the National Blood Transfusion Service (NBTS) in March 2010, which established national blood collection targets. The opportunity is intended to supplement NBTS efforts and help the country catch up on missed milestones and still meet collection goals.
What is NBTS and what role does it play?
The National Blood Transfusion Service (NBTS) is the government agency leading Tanzania’s national blood transfusion program. It was originally established with CDC support in 2004 and is described as the national entity responsible for the program and its targets.
How is NBTS funded according to the announcement?
The announcement states that CDC provides the majority of NBTS funding (about 80 percent), with the remaining 20 percent supported by the Ministry of Health and Social Welfare.
Why is the opportunity limited in practice to organizations with existing infrastructure in Tanzania?
The notice emphasizes that Tanzania cannot afford delays caused by building new systems and needs immediate scale-up using infrastructure that is already in place and functioning. The opportunity is therefore described as requiring an organization that can immediately leverage existing blood collection infrastructure operating in Tanzania.
Which entities are described as having blood collection capacity and infrastructure in Tanzania?
The announcement identifies only three entities as having the capacity and infrastructure to collect blood for transfusions in Tanzania: NBTS, the Tanzanian People’s Defense Force (TPDF), and the Tanzania Red Cross Society (TRCS).
What is TPDF’s blood collection role as described?
TPDF is described as having limited blood collection activity funded via a sub-grant from NBTS, with collections narrow in scope because donor recruitment is largely restricted to military service members.
Why does the announcement point to TRCS as uniquely positioned for this award?
The narrative states TRCS is the only non-governmental organization with the necessary existing infrastructure to supplement NBTS blood collection and coordinate technical assistance using systems already in place and functioning, which aligns with the urgent need for rapid scale-up.
What is the funding mechanism for this opportunity?
The funding instrument is a cooperative agreement, which the announcement characterizes as involving substantial CDC programmatic involvement rather than simply providing funds with minimal oversight.
What does CDC “substantial involvement” typically imply for a cooperative agreement?
Based on the announcement’s description, substantial involvement typically implies close collaboration with CDC on planning, performance monitoring, technical guidance, and alignment with national strategies and PEPFAR priorities.
What is the estimated total funding amount and the award ceiling?
The award profile lists an estimated total funding amount of 7,500,000 and an award ceiling of 1,500,000.
How many awards were expected?
The opportunity indicates an expected number of awards of one.
Is cost sharing or matching required?
No cost sharing or matching requirement is listed in the information provided.
What is the funding activity category?
The funding activity category is health.
What is the CFDA number and what does it indicate?
The CFDA number is 93.067 (Global AIDS). This reflects PEPFAR alignment and the broader HIV-related public health rationale for strengthening transfusion safety and availability.
What geographic areas does the opportunity cover?
The opportunity is focused on the United Republic of Tanzania and Zanzibar.
Does the announcement emphasize safety as well as increased volume of blood?
Yes. The goal is to increase the supply of safe blood for transfusion. The description implies maintaining standards that protect recipients from transfusion-transmitted infections and ensure appropriate handling and processing while scaling up collection.
What were the key dates for this opportunity?
The timeline provided shows the opportunity was posted March 23, 2012, created March 30, 2012, and closed May 7, 2012. The archive date is June 6, 2012.
How was eligibility presented in the listing?
The eligible applicants field is listed as “Others (see text field entitled Additional Information on Eligibility for clarification),” and the narrative further constrains eligibility in practice by emphasizing the need for immediate, existing blood collection infrastructure in Tanzania.
Where could applicants direct access and administrative questions?
The opportunity lists the CDC Procurement and Grant Office as the contact point for access and administrative questions: pgotim@cdc.gov and 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Expanding Comprehensive HIV Prevention Programs for People Who Inject Drugs and People Who Use Drugs in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR
Previous opportunity: STRATEGIC EDUCATION ALLIANCE
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH12 1235
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH12 1235) also looked into and applied for these:
| Funding Opportunity |
|---|
| Expanding Comprehensive HIV Prevention Programs for People Who Inject Drugs and People Who Use Drugs in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR Apply for CDC RFA GH12 1238 Funding Number: CDC RFA GH12 1238 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Strengthening Civil Society Organizations to support vulnerable populations in Rwanda Apply for APS 696 12 00001 Funding Number: APS 696 12 00001 Agency: Rwanda USAID Kigali Category: Health Funding Amount: $4,500,000 |
| Drug Free Communities Mentoring Program Apply for SP 12 002 Funding Number: SP 12 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $75,000 |
| MCH Pediatric Research Network Program Apply for HRSA 12 019 Funding Number: HRSA 12 019 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Nurse Faculty Loan Program (NFLP) Apply for HRSA 12 064 Funding Number: HRSA 12 064 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening the quality and scope of undergraduate and postgraduate medical and public health training programs at the University of Zambia, School of Medicine in the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief (PEPFAR Apply for CDC RFA GH12 1241 Funding Number: CDC RFA GH12 1241 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Building a Medical Home for Multiply Diagnosed HIV positive Homeless Populations Demonstration Sites Apply for HRSA 12 100 Funding Number: HRSA 12 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Building a Medical Home for HIV positive Multiply Diagnosed Homeless Populations Initiative Evaluation and Technical Assistance Center Apply for HRSA 12 104 Funding Number: HRSA 12 104 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Partnerships for Sustainable Research and Dissemination of Evidence based Medicine (R24) Apply for RFA HS 12 005 Funding Number: RFA HS 12 005 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $300,000 |
| Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44) Apply for RFA EB 12 001 Funding Number: RFA EB 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Strengthening Blood Donor Associations in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1223 Funding Number: CDC RFA GH12 1223 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Public Health Conference Support for Birth Defects and Developmental Disabilities Apply for CDC RFA DD12 1203 Funding Number: CDC RFA DD12 1203 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Building the capacity of the National AIDS Control Program of the Ministry of Health to Expand Coordinated HIV Prevention, Care, Treatment, and Strategic Information Programs in the United Republic of Tanzania under the Presidents Emergency Plan for Apply for CDC RFA GH12 1240 Funding Number: CDC RFA GH12 1240 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Partnerships for Interventions to Treat Chronic, Persistent and Latent Infections (R21/R33) Apply for RFA AI 12 020 Funding Number: RFA AI 12 020 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) Apply for PAR 12 120 Funding Number: PAR 12 120 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Child Survival Health Grants Program Fiscal Year 2012 Apply for RFA OAA 12 000008 Funding Number: RFA OAA 12 000008 Agency: Agency for International Development Category: Health Funding Amount: $13,500,000 |
| Initiative to Reduce Avoidable Hospitalizations among Nursing Facility Residents Apply for CMS 1E1 12 002 Funding Number: CMS 1E1 12 002 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $30,000,000 |
| Studies in Parkinsons Disease Biomarkers Discovery (U01) Apply for RFA NS 12 011 Funding Number: RFA NS 12 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Laboratory and Analysis Projects in Parkinsons Disease Biomarkers (U18) Apply for RFA NS 12 010 Funding Number: RFA NS 12 010 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01) Apply for PAR 12 123 Funding Number: PAR 12 123 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1235", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.